Avita Medical, INC Form 4 insider transactions

NASDAQ
Director Robert McNamara of Avita Medical, Inc. [RCEL] purchased 10,000 shares of common stock at an average price of $10.09 on February 20, 2025.
NASDAQ
Avita Medical's CFO, David O'Toole, purchased 1,000 shares of the company's common stock at $9.90 per share on February 20, 2025.
NASDAQ
David O'Toole, CFO of Avita Medical, Inc., purchased 1,000 shares of common stock at $10.25 per share on February 19, 2025.
NASDAQ
Director Suzanne Crowe purchased 486 shares of Avita Medical, Inc. common stock at $13.15 per share on December 9, 2024.
NASDAQ
David O'Toole, CFO of Avita Medical, Inc., acquired 150,000 stock options on January 21, 2025, vesting in three equal annual installments.
NASDAQ
Nicole Kelsey, Chief Legal Officer of Avita Medical, Inc., reports the acquisition of 65,000 stock options on January 21, 2025.
NASDAQ
AVITA Medical's CFO, David O'Toole, has reported the acquisition of company shares through the Employee Share Purchase Plan and open market purchases.
NASDAQ
Robert McNamara, a director of AVITA Medical, Inc., acquired 10,000 shares of common stock at $9 per share on August 19, 2024, and disposed of 35,749 shares.
NASDAQ
Director Lou Panaccio reports acquisition of shares and stock options in Avita Medical, Inc.
NASDAQ
Director Suzanne Crowe reported the acquisition of 9,200 shares of common stock and 3,943 stock options in Avita Medical, Inc.
NASDAQ
Director Jeremy Curnock Cook reports acquisition of 9,200 shares of common stock and 3,943 stock options in Avita Medical, Inc.
NASDAQ
Director Jan Stern Reed of Avita Medical, Inc. reports acquisition of common stock and stock options.
NASDAQ
Director Robert McNamara reports acquisition of AVITA Medical shares and stock options.
NASDAQ
Director Cary Guy Vance of Avita Medical, Inc. reports acquisition of shares and stock options.
NASDAQ
Avita Medical's CEO, James Corbett, received 350,000 stock options after shareholder approval, vesting annually over three years.
NASDAQ
Donna Shiroma, General Counsel of AVITA Medical, reports acquiring 2,225 shares of common stock through the company's Employee Share Purchase Plan (ESPP) at a discounted price.
NASDAQ
David O'Toole, CFO of AVITA Medical, recently acquired shares of the company's common stock through open market purchases and the Employee Share Purchase Plan.
NASDAQ
David O'Toole, CFO of AVITA Medical, recently purchased shares of the company's common stock, signaling potential confidence in the company's future.